PortfolioTeam
TwitterLinkedinFacebookInstagramYoutubeSubstack
Loading job description…
a16z

Software Is Eating the World

XLinkedInSubstack
© 2026 Andreessen Horowitz.
All Portfolio JobsCompaniesDisclosures
All portfolio jobs/Aktis Oncology
Aktis Oncology

a16z portfolio company

Senior Manager, Drug Substance Manufacturing

Compensation
USD 144,000–176,000 / year

About the role

Posted Sep 16, 2026

Aktis Oncology, Inc. is a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies. Aktis' most advanced program, AKY-1189, is a miniprotein radioconjugate targeting Nectin-4, with multi-indication potential across multiple tumor types. Aktis' second pipeline program, AKY-2519, is a miniprotein radioconjugate targeting B7-H3-expressing tumors, including prostate, lung, and other solid tumors. Aktis has a strategic collaboration with Eli Lilly and Company to leverage its miniprotein platform to develop novel radioconjugates outside Aktis' proprietary pipeline.

The Senior Manager, Drug Substance (DS) Manufacturing, is responsible for the day-to-day planning, coordination, and oversight of outsourced manufacturing activities for peptide drug substance across Aktis’ development portfolio. This individual will report to the Associate Director, DS Manufacturing and be an integral part of the Chemistry, Manufacturing, and Controls (CMC) team contributing to the development of multiple portfolio programs. The ideal candidate combines strong technical judgment with external-partner management and thrives in a fast-paced, mission-driven environment.

ESSENTIAL DUTIES / RESPONSIBILITIES

  • Manage day-to-day operations of external peptide/miniprotein manufacturing activities from development through clinical supply.
  • Manage and coordinate process development, scale-up, technology transfer, GMP manufacturing, and analytical testing activities at external partners. 
  • Support review of manufacturing documents, including protocols, batch records, campaign plans, and technical reports.
  • Monitor stability studies, including sample pulls, testing schedules, data availability, and report timelines, and escalate delays or unexpected results.
  • Drive investigations, deviations, change controls, and corrective and preventive actions in partnership with Quality.
  • Partner with Supply Chain and Operations to support material availability, manufacturing schedules, and demand planning.
  • Manage CDMO contracts, statements of work, purchase orders, change orders, invoice tracking, and budget reconciliation in partnership with senior team members, Finance, and Procurement.

BACKGROUND AND QUALIFICATIONS

  • Bachelor's degree or higher in chemistry, chemical engineering, biochemistry, pharmaceutical sciences, or related discipline
  • 5+ years of experience in peptide, biologics, or small-molecule process development and/or external manufacturing within the biotechnology or pharmaceutical industry
  • Direct experience with solid-phase peptide synthesis, analytical testing, and characterization is preferred
  • Experience managing CDMOs and coordinating multidisciplinary technical programs
  • Strong working knowledge of cGMP regulations and validation principles
  • Strong analytical, problem-solving, and communication skills
  • Excellent interpersonal skills and a collaborative approach with internal teams and external vendors
  • Able to work independently with minimal supervision
  • Self-starter who can prioritize and adapt in a fast-paced startup environment

Aktis Oncology is an Equal Opportunity Employer and does not discriminate on the basis of race, religion, color, sex, gender identity or expression, sexual orientation, age, disability, national origin, veteran status, or any other basis covered by appropriate law. Aktis Oncology is committed to promoting and maintaining a work environment in which all applicants, employees, and other individuals are treated with dignity and respect free from unlawful harassment, discrimination, or retaliation.

Explore what’s next at Aktis Oncology.

Apply for this role

At a glance

Compensation
USD 144,000–176,000 / year
Apply for this role

You’ll be taken to Aktis Oncology to apply.

The company

Aktis Oncology

Aktis Oncology

Miniprotein-based alpha radiopharmaceuticals for oncology

IPO51–200 employeesBio + Health
More roles at Aktis Oncology

Explore what’s next at Aktis Oncology.

Apply for this role